BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35899856)

  • 41. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.
    Wu Y; Xie Z; Chen J; Chen J; Ni W; Ma Y; Huang K; Wang G; Wang J; Ma J; Shen S; Fan S
    Mol Cancer; 2019 Apr; 18(1):73. PubMed ID: 30940151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA HCG18 Promotes Osteosarcoma Cells Proliferation, Migration, and Invasion in by Regulating miR-34a/RUNX2 Pathway.
    Chen YP; Zhang DX; Cao Q; He CK
    Biochem Genet; 2023 Jun; 61(3):1035-1049. PubMed ID: 36401685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
    Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
    Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β-catenin/cyclin D1 signaling via PLAGL2.
    Liu Q; Ran R; Song M; Li X; Wu Z; Dai G; Xia R
    Cell Biol Toxicol; 2022 Dec; 38(6):979-993. PubMed ID: 34331612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 46. Long Non-Coding RNA Urothelial Carcinoma Associated 1 Promotes Proliferation, Migration and Invasion of Osteosarcoma Cells by Regulating microRNA-182.
    Li Q; Xing W; Gong X; Wang Y
    Cell Physiol Biochem; 2018; 51(3):1149-1163. PubMed ID: 30481751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TYMSOS-miR-101-3p-NETO2 axis promotes osteosarcoma progression.
    Zhang Z; Wang J; Zhang X; Ran B; Wen J; Zhang H
    Mol Cell Probes; 2023 Feb; 67():101887. PubMed ID: 36509232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
    Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
    Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
    Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
    Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.
    Sun Y; Wang P; Yang W; Shan Y; Zhang Q; Wu H
    Cancer Biol Ther; 2019; 20(6):729-739. PubMed ID: 30915884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-361-3p promotes tumorigenesis of osteosarcoma cells via targeting ARID3A.
    Zhou D; Ji G; Wei G; Li Z; Yu N; Wang Y; Lin B; Zhang L; Yin Y
    Tissue Cell; 2022 Jun; 76():101759. PubMed ID: 35219069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hox transcript antisense RNA knockdown inhibits osteosarcoma progression by regulating the phosphoinositide 3-kinase/AKT pathway through the microRNA miR-6888-3p/spleen tyrosine kinase axis.
    Wu W; Wang L; Li S
    Bioengineered; 2022 Apr; 13(4):9397-9410. PubMed ID: 35435107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effect of Long Non-Coding RNA (lncRNA) HCP5 on Regulating Epithelial-Mesenchymal Transition (EMT)-Related Markers in Gastric Carcinoma Is Partially Reversed by miR-27b-3p.
    Chen S; Ren C; Zheng H; Sun X; Dai J
    Med Sci Monit; 2020 May; 26():e921383. PubMed ID: 32357145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.
    Shuang O; Zhou J; Cai Z; Liao L; Wang Y; Wang W; Xu M
    J Orthop Surg Res; 2022 Jun; 17(1):332. PubMed ID: 35761386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
    Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W
    Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.